Ilg M - Search Results

1

Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors.

Zechmann CM, Woenne EC, Brix G, Radzwill N, Ilg M, Bachert P, Peschke P, Kirsch S, Kauczor HU, Delorme S, Semmler W, Kiessling F. Zechmann CM, et al. Among authors: ilg m. Neoplasia. 2007 Jan;9(1):57-67. doi: 10.1593/neo.06688. Neoplasia. 2007. PMID: 17325744 Free PMC article.

2

Heterogeneity of myocardial edema in isolated pig hearts after perfusion with different types of cardioprotective solutions.

Vahl CF, Albers J, Makabe MH, Meinzer HP, Ilg M, Fu X, Szabo G, Mühling J, Hagl S. Vahl CF, et al. Among authors: ilg m. Thorac Cardiovasc Surg. 1998 Oct;46(5):285-92. doi: 10.1055/s-2007-1010240. Thorac Cardiovasc Surg. 1998. PMID: 9885120

3

TGF-β1 induces formation of TSG-6-enriched extracellular vesicles in fibroblasts which can prevent myofibroblast transformation by modulating Erk1/2 phosphorylation.

Ilg MM, Bustin SA, Ralph DJ, Cellek S. Ilg MM, et al. Sci Rep. 2024 May 29;14(1):12389. doi: 10.1038/s41598-024-62123-x. Sci Rep. 2024. PMID: 38811625 Free PMC article.

4

Temporal gene signature of myofibroblast transformation in Peyronie's disease: first insights into the molecular mechanisms of irreversibility.

Ilg MM, Harding S, Lapthorn AR, Kirvell S, Ralph DJ, Bustin SA, Ball G, Cellek S. Ilg MM, et al. J Sex Med. 2024 Mar 28;21(4):278-287. doi: 10.1093/jsxmed/qdae006. J Sex Med. 2024. PMID: 38383071

5

Hydroxypyridone anti-fungals selectively induce myofibroblast apoptosis in an in vitro model of hypertrophic scars.

Lapthorn AR, Ilg MM, Dziewulski P, Cellek S. Lapthorn AR, et al. Among authors: ilg mm. Eur J Pharmacol. 2024 Mar 15;967:176369. doi: 10.1016/j.ejphar.2024.176369. Epub 2024 Feb 5. Eur J Pharmacol. 2024. PMID: 38325796 Free article.

6

European Society of Sexual Medicine consensus statement on the use of animal models for studying Peyronie's disease.

Castiglione F, Çakır OÖ, Schifano N, Corona G, Reisman Y, Bettocchi C, Cellek S, Ilg MM. Castiglione F, et al. Among authors: ilg mm. Sex Med. 2023 Aug 2;11(4):qfad046. doi: 10.1093/sexmed/qfad046. eCollection 2023 Aug. Sex Med. 2023. PMID: 37547872 Free PMC article.

7

A combination of phosphodiesterase type 5 inhibitor and tamoxifen for acute Peyronie's disease: the first clinical signals.

Cellek S, Megson M, Ilg MM, Ralph DJ. Cellek S, et al. Among authors: ilg mm. J Sex Med. 2023 Jul 31;20(8):1057-1059. doi: 10.1093/jsxmed/qdad083. J Sex Med. 2023. PMID: 37524687 No abstract available.

8

Statins synergize with phosphodiesterase type 5 inhibitors but not with selective estrogen receptor modulators to prevent myofibroblast transformation in an in vitro model of Peyronie's disease.

Ilg MM, Ralph DJ, Cellek S. Ilg MM, et al. J Sex Med. 2023 Jun 28;20(7):925-934. doi: 10.1093/jsxmed/qdad051. J Sex Med. 2023. PMID: 37082866

9

Phenotypic screening of 1,953 FDA-approved drugs reveals 26 hits with potential for repurposing for Peyronie's disease.

Ilg MM, Lapthorn AR, Ralph DJ, Cellek S. Ilg MM, et al. PLoS One. 2022 Dec 12;17(12):e0277646. doi: 10.1371/journal.pone.0277646. eCollection 2022. PLoS One. 2022. PMID: 36508413 Free PMC article.

10

Phenotypic screening identifies hydroxypyridone anti-fungals as novel medicines for the prevention of hypertrophic scars.

Lapthorn AR, Ilg MM, Sullivan JV, Dziewulski P, Cellek S. Lapthorn AR, et al. Among authors: ilg mm. Eur J Pharmacol. 2022 Dec 15;937:175374. doi: 10.1016/j.ejphar.2022.175374. Epub 2022 Nov 5. Eur J Pharmacol. 2022. PMID: 36343693 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters